Dr. Pasche directs Michigan’s largest cancer provider and research network, setting strategy across clinical growth, scientific direction, community engagement and faculty recruitment in partnership with the Wayne State University School of Medicine, where he chairs the oncology department. He has advanced a statewide expansion that includes a 50,000-square-foot, $48 million build-out, new medical oncology clinics, a multispecialty site in partnership with Grand Blanc, Mich.-based McLaren Health Care, and a partnership with Michigan State University to open a new state-of-the-art cancer center in Lansing, Mich. He has recruited 10 physicians and 12 researchers, and is planning a $200 million academic and research tower with Wayne State University to accelerate discovery and education. A physician-scientist and co-inventor of the TheraBionic P1 device, an FDA-approved, noninvasive therapy for advanced hepatocellular carcinoma, Dr. Pasche led Karmanos to become the first site worldwide to offer the treatment in November 2024. He has prior leadership experience at Winston-Salem, N.C.-based Wake Forest Baptist Comprehensive Cancer Center and the University of Alabama at Birmingham, and founded the cancer genetics program at Northwestern University.
